Sun. May 31st, 2020


Shenango Valley Makers

Prellis Biologics raises $8.7M following first animal transplant of 3D printed tissue

San Francisco biotechnology company Prellis Biologics has successfully raised $8.7 million to advance its holographic 3D bioprinting platform. A Series A investment led by specialist technology capital firm Khosla Ventures, the round was joined by seed contributors True Ventures and Indie Bio. The successful fundraising follows a number of developments at the company including, most recently, pre-clinical experimentation […]

Go to Source
Author: Beau Jackson